Analysis of 2 companies

King Pharmaceuticals is amongst the world 's largest pharmaceutical companies . The company provides branded prescription pharmaceutical products worldwide . The company began operations in 1993 , and subsequently , in 1994 , it acquired a former Beecham plant in Bristol

Initially King Pharmaceuticals only manufactured drugs for other companies , but later it adopted to its long known strategy of acquiring branded prescription drugs . The reason for this switch in strategy was that branded prescription drugs have a much higher gross margin as compared to contract manufactured drugs

King Pharmaceutical hit a jackpot in 1998 , when

they purchased their most successful drug , Altace , for a sum of 362 .5 million (KG : Pro for King Pharmaceuticals , 2008 . Altace 's sales soon went through the roof . Since then , King has continued to add to its product line several other prescription drugs . King also purchased an R D company in 2000 , in to strengthen its research segment , which played an important role in determining which branded prescription drug the company should acquire . Two years later , in 2002 , the founder John Gregory , stepped down as the CEO (KG : Pro for King Pharmaceuticals , 2008 . Later in 2004 , Mylan Laboratories made a deal to acquire King Pharmaceuticals for 4 billion . However , some investors believed that Mylan was overpaying for the merger , which is why next year it was called off

Elan Corp . is one of the major drug manufacturing firms in the world . It is based in Ireland , but has vested interests in the United States . It was founded in...